AEON Biopharma, Inc.
AEON
$0.24
$0.000.60%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -23.37% | 11.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.13% | 16.39% | |||
| Operating Income | 0.13% | -16.39% | |||
| Income Before Tax | 90.21% | 68.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 90.21% | 68.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 90.21% | 68.24% | |||
| EBIT | 0.13% | -16.39% | |||
| EBITDA | 0.15% | -16.47% | |||
| EPS Basic | 92.11% | 89.92% | |||
| Normalized Basic EPS | 74.40% | 95.04% | |||
| EPS Diluted | 92.11% | 89.92% | |||
| Normalized Diluted EPS | 74.40% | 95.04% | |||
| Average Basic Shares Outstanding | 24.42% | 215.04% | |||
| Average Diluted Shares Outstanding | 24.42% | 215.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||